Anemia is a condition where blood is deficient in red blood cells (RBCs). Pernicious anemia occurs when the body’s capacity to absorb vitamin B12, which is required to make healthy red blood cells, is reduced. It is a rare condition. As per the Journal of Blood Medicine, the prevalence of pernicious anemia is about 0.1% in the normal population, while in aged people (people over 60 years) the prevalence is about 1.9%. Previously, the disease was incurable due to lack of available treatment options. However, it is now easily treatable due to availability of medicines. The symptoms of pernicious anemia are not severe initially, and therefore it is difficult to diagnose. Commonly occurring symptoms include weakness, headaches, weight loss, and in rare cases some neurological problems. The most important sources of vitamin B12 include meat, eggs, poultry, dairy products, and nutritional supplements. In moderate to severe cases, vitamin B12 injections are provided to the patient to counteract deficiency symptoms. Vitamin B12 is available in the form of cyanocobalamin or hydroxocobalamin injections. When vitamin B12 levels are close to normal after treatment with injections, oral doses in the form of pills, sprays, and gels can be provided.

High prevalence of the condition is a major factor likely to drive the global pernicious anemia treatment market during the forecast period. Development of pipeline products, high number of women of reproductive age, unhealthy lifestyle, and complications during pregnancy primarily in developing countries are some of the factors expected to propel the global pernicious anemia treatment market during the forecast period. Furthermore, increase in geriatric population, robust R&D, and improving health care infrastructure are projected to boost the global pernicious anemia treatment market. However, factors such as lack of awareness about health in several developing countries and high cost of drugs are anticipated to restrain the global pernicious anemia treatment market during the forecast period.

The global pernicious anemia treatment market can be segmented based on the route of administration of drug, region, and distribution channel. Based on the route of administration, the pernicious anemia treatment market can be classified into parenteral, oral, nasal, and topical.  The parenteral route segment accounts for a dominant share of the market due to higher availability and stability of drugs in the injectable form and major requirement of drugs in the injectable form during urgencies .In terms of distribution channel, the global pernicious anemia treatment market can be categorized into retail store, pharmacy, and e-commerce. The e-commerce segment is expected to account for a prominent market share in 2025 as shopping online offers convenience to consumers.

Based on region, the global pernicious anemia treatment market can be divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to account for a significant share of the global pernicious anemia treatment market during the forecast period. Rise in incidence of the condition and unhealthy lifestyle are projected to drive the pernicious anemia treatment market in this region. Furthermore, increase in health care expenditure, advanced technology, increase in research activities, and rise in awareness about pernicious anemia are expected to augment the pernicious anemia treatment market in North America. Europe is also anticipated to hold a prominent share of the global pernicious anemia treatment market. The pernicious anemia treatment market in Asia Pacific is expected to expand at a rapid pace during the forecast period due to increase in health care expenditure, rise in geriatric population, surge in disposable income, high prevalence of chronic diseases, increase in awareness, and complications during pregnancy in many rural areas.

Key players operating in the global anemia drugs market are AMAG Pharmaceuticals GlaxoSmithKline, Takeda Pharmaceutical Company Limited, Sanofi, Galenica, Daiichi Sankyo, and Pharmacosmos.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Pernicious Anemia Treatment Market

Pre Book